Effect of 5-HT on binding of [(11)C] WAY 100635 to 5-HT(IA) receptors in rat brain, assessed using in vivo microdialysis nd PET after fenfluramine.
about
5-HT(1A) receptor function in major depressive disorderApplication of cross-species PET imaging to assess neurotransmitter release in brainTranscriptional regulation of the 5-HT1A receptor: implications for mental illnessIn vivo evidence that 5-HT(2C) receptors inhibit 5-HT neuronal activity via a GABAergic mechanismConfirmation of fenfluramine effect on 5-HT(1B) receptor binding of [(11)C]AZ10419369 using an equilibrium approachFunctional neuroimaging of genetic variation in serotonergic neurotransmission.Evaluation of [C]S14506 and [F]S14506 in rat and monkey as agonist PET radioligands for brain 5-HT(1A) receptors.Acute effect of the anti-addiction drug bupropion on extracellular dopamine concentrations in the human striatum: an [11C]raclopride PET studyAssessing the sensitivity of [¹¹C]p943, a novel 5-HT1B radioligand, to endogenous serotonin release.Measurement of 5-HT1A receptor binding in depressed adults before and after antidepressant drug treatment using positron emission tomography and [11C]WAY-100635.Sleep deprivation increases cerebral serotonin 2A receptor binding in humansReduced post-synaptic serotonin type 1A receptor binding in bipolar depression.Measuring endogenous 5-HT release by emission tomography: promises and pitfalls.In vivo serotonin-sensitive binding of [11C]CUMI-101: a serotonin 1A receptor agonist positron emission tomography radiotracer.Further evaluation of the carbon11-labeled D(2/3) agonist PET radiotracer PHNO: reproducibility in tracer characteristics and characterization of extrastriatal binding.Serotonin 5HT1A receptor availability and pathological crying after stroke.Initial in vivo PET imaging of 5-HT1A receptors with 3-[(18)F]mefway.Modeling [18 F]MPPF positron emission tomography kinetics for the determination of 5-hydroxytryptamine(1A) receptor concentration with multiinjection.Serotonin modulation of cerebral glucose metabolism measured with positron emission tomography (PET) in human subjects.Imaging the GABA-benzodiazepine receptor subtype containing the alpha5-subunit in vivo with [11C]Ro15 4513 positron emission tomography.5-HT(1A) receptor imaging in the human brain: effect of tryptophan depletion and infusion on [(18)F]MPPF binding.Influence of escitalopram treatment on 5-HT 1A receptor binding in limbic regions in patients with anxiety disorders.Occupancy of agonist drugs at the 5-HT1A receptor.Effects of serotonin transporter promoter polymorphisms on serotonin function.[18F]altanserin binding to human 5HT2A receptors is unaltered after citalopram and pindolol challenge.A positron emission tomography study of the 5-HT1A receptor in schizophrenia and during clozapine treatment.Effect of increased serotonin levels on [18F]MPPF binding in rat brain: fenfluramine vs the combination of citalopram and ketanserin.Wide impairment of cerebral serotoninergic activity but inter-individual heterogeneity in bulimia nervosa patients: a pilot [(18)F]MPPF/PET study.Ex vivo evaluation of the serotonin 1A receptor partial agonist [3H]CUMI-101 in awake rats
P2860
Q24643511-71917E4A-CAB4-4187-83A1-D8B7BA2710D3Q26865012-2007ED82-AE19-4B9B-8DFE-86709B864948Q26999691-C05DE88A-7184-4E2F-8C7C-57C1CD422F47Q28565374-22170900-3F30-4EA1-BE39-89AE261EBC3DQ30512685-DE8E94A8-D542-4767-B558-000DD2730175Q30885282-12D0B192-FB9F-4B17-9C57-F76215F07867Q34011564-969108EC-308D-41B5-B398-2AD25846A5A1Q34054242-7AEED039-CECE-416F-8C56-3B062D27FD07Q35146221-9F4B13FA-A5D0-4E00-B3C7-2277C29F0669Q35662761-972A556B-36AE-45CF-8F09-256EDAF6E282Q36375242-E0A609A6-ED7B-4963-8E63-02FD97F9B59AQ37107181-A353EC6E-0726-49B2-BD68-71FFCC070E61Q37776154-962EA71E-9C37-4FC3-A9A9-152E3AA422A5Q39861017-3D6D677A-6B2B-44A2-85D5-4A6F1862EC6CQ41993350-CD8960CF-510B-488E-B3EE-12DDE24804BEQ42516638-9B684845-D681-413B-A235-C5CD9F8F4831Q42814413-0135FAEC-C8CC-44E5-B73F-83A8D39BBC23Q44015370-AE23C2BE-D578-452E-8B59-E3F51CDA2753Q44060455-DA237882-8F66-48DB-A842-02CEEB6484C8Q44079767-9250D699-2512-47D5-9454-C6546937D7BEQ44125221-2C0FE39B-B72C-4932-A14B-BD67B6EFA5BCQ44355507-D337E01A-017F-4DB1-8881-69E8C970F72FQ44777682-23FF3F9F-F933-49B4-B21A-01602CB57E91Q45049144-E324BDB1-45AB-43C9-A030-DFBEEBE82786Q45050962-A152913F-2811-4E8F-9192-B2EA92A5702DQ45052989-9E86DE5E-91F6-40C3-BD8E-2F1145064C22Q46435462-9BEC46BA-9652-4102-88C3-26A1BDCDD636Q48248612-3AB02B74-919D-4DB3-AA10-D9E225D76963Q53010523-B8B4DD72-6AF8-449A-A88D-BCBAC7F17129
P2860
Effect of 5-HT on binding of [(11)C] WAY 100635 to 5-HT(IA) receptors in rat brain, assessed using in vivo microdialysis nd PET after fenfluramine.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Effect of 5-HT on binding of [ ...... sis nd PET after fenfluramine.
@en
Effect of 5-HT on binding of [ ...... sis nd PET after fenfluramine.
@nl
type
label
Effect of 5-HT on binding of [ ...... sis nd PET after fenfluramine.
@en
Effect of 5-HT on binding of [ ...... sis nd PET after fenfluramine.
@nl
prefLabel
Effect of 5-HT on binding of [ ...... sis nd PET after fenfluramine.
@en
Effect of 5-HT on binding of [ ...... sis nd PET after fenfluramine.
@nl
P2093
P2860
P356
P1433
P1476
Effect of 5-HT on binding of [ ...... sis nd PET after fenfluramine.
@en
P2093
Opacka-Juffry J
Townsend C
P2860
P304
P356
10.1002/SYN.1069
P577
2001-08-01T00:00:00Z